A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.
Eticlopride is a substituted benzamide analog with high affinity and selectivity for dopamine (DA) D2-like receptors that was initially developed as a potential antipsychotic agent. A great deal of research has utilized this drug to better understand central DA receptor function, the role of D2-like receptors in behavior, and the influence of blockade of these receptors on several preclinical animal models. This review highlights research utilizing this drug and compares it to typical and atypical antipsychotics used clinically. First, we describe structure-activity relationships as it relates to binding at DA receptors and the consequences on behavior. This is followed by a discussion of several imaging strategies including the use of eticlopride for in vivo, in vitro, and ex vivo examination of DA D2-like receptor densities and function. Finally, we discuss the use of eticlopride in several behavioral models predictive of antipsychotic activity, extrapyramidal side effects (EPS), and learning and memory. While eticlopride is not used clinically, it remains a viable research tool for understanding DA receptor function and behavior.
Martelle
Jennifer L
JL
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1083, USA.
Nader
Michael A
MA
D000818:Animals; D014150:Antipsychotic Agents / Q000737:chemistry / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D012457:Salicylamides / Q000737:chemistry / Q000494:pharmacology*; D015398:Signal Transduction / Q000502:physiology
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D012457:Salicylamides; C045989:eticlopride; D004298:Dopamine
Mol Cell Biochem. 1983;53-54(1-2):129-52
6137760
Synapse. 2005 Dec 15;58(4):215-9
16206180
Proc Natl Acad Sci U S A. 1974 Apr;71(4):1113-7
4151517
Lancet. 1993 Nov 13;342(8881):1244-5
7901566
Physiol Behav. 1997 Apr;61(4):563-7
9108576
Annu Rev Neurosci. 1983;6:43-71
6220666
Prog Clin Biol Res. 1989;291:369-72
2726875
Trends Neurosci. 1991 Jan;14(1):21-7
1709528
J Pharm Sci. 1994 Mar;83(3):305-15
8207673
Pharm Res. 2002 Aug;19(8):1150-9
12240941
Eur J Pharmacol. 1978 Aug 15;50(4):459-61
699970
Science. 1953 Aug 7;118(3058):157-8
13076224
Med J Aust. 1994 May 2;160(9):591
8018165
Behav Pharmacol. 1994 Apr;5(2):141-152
11224262
Mol Pharmacol. 1994 Jan;45(1):51-60
8302280
Science. 1986 Dec 19;234(4783):1558-63
2878495
Behav Pharmacol. 1990;1(6):469-490
11175433
Nature. 1990 Sep 13;347(6289):146-51
1975644
Proc Natl Acad Sci U S A. 1972 Aug;69(8):2145-9
4403305
J Med Chem. 1985 Sep;28(9):1263-9
4040977
Med Res Rev. 1988 Oct-Dec;8(4):475-97
2903950
Acta Pharmacol Toxicol (Copenh). 1986 Jan;58(1):61-70
2869639
J Pharmacol Exp Ther. 1994 Aug;270(2):475-9
8071839
Psychopharmacol Commun. 1975;1(6):663-73
1241457
Arch Gen Psychiatry. 1993 Feb;50(2):85-94
8427558
Psychopharmacology (Berl). 1980;69(2):225-6
6779316
Pharmacol Rev. 1980 Sep;32(3):229-313
6117090
Neuroscience. 1991;45(2):359-71
1762683
J Med Chem. 1982 Nov;25(11):1280-6
6128419
Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(6):885-93
1837159
Acta Psychiatr Scand. 1992 Nov;86(5):391-8
1485530
Behav Pharmacol. 2000 Jun;11(3-4):223-33
11103877
Neurosci Lett. 1976 Dec;3(5-6):335-9
19604908
Psychopharmacology (Berl). 1988;94(1):1-7
3126517
Acta Pharm Suec. 1985;22(2):101-10
4050456
Pharmacol Biochem Behav. 1981 Feb;14(2):181-92
6111088
J Med Chem. 1986 Jan;29(1):61-9
3941414
C R Acad Sci III. 1990;311(13):501-8
2129115
Neuroscience. 1991;41(2-3):473-81
1678501
Acta Pharm Suec. 1979;16(4):239-46
44421
Pharmacol Biochem Behav. 1992 Jan;41(1):29-35
1347175
J Psychiatry Neurosci. 1995 Jul;20(4):287-96
7647082
J Exp Anal Behav. 1991 Sep;56(2):239-60
1955815
Chem Pharm Bull (Tokyo). 1992 Jul;40(7):1793-8
1394695
Neuropharmacology. 1986 Feb;25(2):187-97
2939362
Nature. 1976 Jun 24;261(5562):717-9
945467
Eur J Pharmacol. 1993 Jul 6;238(1):121-5
8405075
Arch Gen Psychiatry. 2006 Jun;63(6):679-85
16754841
Behav Pharmacol. 1990;1(4):355-363
11175420
Eur J Pharmacol. 1979 Jul 1;56(4):411-2
477735
Behav Neurosci. 2000 Jun;114(3):647-51
10883814
Nature. 1990 Sep 6;347(6288):72-6
2144334
Eur J Pharmacol. 1975 May;32(1):87-92
1171020
Neuropsychopharmacology. 1987 Dec;1(1):5-15
2908095
Neuroscience. 2000;96(3):451-74
10717427
Int Clin Psychopharmacol. 1989 Jan;4(1):61-70
2531773
Int J Rad Appl Instrum A. 1990;41(7):669-74
2170298
Int J Rad Appl Instrum B. 1990;17(4):347-56
2143753
Psychopharmacology (Berl). 1978 Apr 11;56(3):239-47
26097
Acta Pharm Suec. 1987;24(6):289-328
2898864
Brain Res. 1991 Nov 15;564(2):203-19
1839781
Neurosci Lett. 1986 May 6;66(1):85-90
2940480
J Neural Transm (Vienna). 1996;103(10):1163-75
9013403
Eur J Pharmacol. 1973 Oct;24(1):8-24
4796448
Eur J Pharmacol. 1994 Feb 21;253(1-2):167-9
8013542
J Histochem Cytochem. 1987 Aug;35(8):917-28
2439585
Science. 1975 Jun 13;188(4193):1084-9
2976
Prog Neuropsychopharmacol Biol Psychiatry. 1994 May;18(3):619-23
8078994
Proc Natl Acad Sci U S A. 1985 Jun;82(11):3863-7
3873656
Neurosci Lett. 1979 Jun;13(1):51-6
572522
Schizophr Bull. 1988;14(2):209-16
3059468
Eur J Pharmacol. 1993 Nov 16;249(3):R9-10
8287911
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11271-5
7972046
Curr Pharm Des. 2003;9(8):673-96
12570798
Med Hypotheses. 1984 May;14(1):69-81
6146915
J Neurosci. 1982 Jul;2(7):895-906
6124583
Acta Pharmacol Toxicol (Copenh). 1963;20:140-4
14060771
Nature. 1988 Dec 22-29;336(6201):783-7
2974511
J Pharmacol Exp Ther. 1994 Jan;268(1):495-502
8301592
Eur J Pharmacol. 1978 Jun 1;49(3):295-9
658143
J Nucl Med. 1991 Aug;32(8):1593-600
1831229
Lancet. 1995 Sep 16;346(8977):743-9
7658878
Pharmacol Res. 1995 May;31(5):261-7
7479522
Adv Exp Med Biol. 1988;235:55-63
2976254
Synapse. 1987;1(2):133-52
2905529
Nature. 1991 Apr 18;350(6319):610-4
1840645
Eur J Clin Pharmacol. 1980 May;17(5):385-91
7418717
Trends Pharmacol Sci. 1992 Feb;13(2):61-9
1561715
Psychopharmacology (Berl). 1999 Nov;147(2):143-52
10591881
Drug Des Discov. 1993;9(3-4):333-50
8400011
Eur J Pharmacol. 1976 Jan;35(1):45-58
3421
Psychopharmacology (Berl). 1998 Nov;140(1):81-90
9862406
Psychopharmacol Bull. 1991;27(1):47-50
1677773
Pharmacol Toxicol. 1993 Dec;73(6):325-34
8153056
Neuropeptides. 2001 Oct-Dec;35(5-6):204-10
12030803
Eur J Pharmacol. 1993 Aug 3;239(1-3):269-70
8223909
Life Sci. 1979 Aug 6;25(6):479-85
40086
Psychopharmacology (Berl). 2000 Mar;148(4):355-60
10928307
Eur J Pharmacol. 1979 Jun 15;56(3):291-2
477726
Acta Psychiatr Scand. 1993 Feb;87(2):114-7
8447237
Eur J Pharmacol. 1985 May 8;111(2):191-9
4018125
J Med Chem. 1993 Jan 22;36(2):196-204
8423592
Eur J Pharmacol. 1986 Jan 21;120(2):217-26
3948920
Psychopharmacology (Berl). 1993;112(2-3):371-4
7871044
J Nucl Med. 2006 Feb;47(2):302-12
16455637
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6723-7
2168556
Synapse. 1996 Jun;23(2):115-23
8723716
Proc Natl Acad Sci U S A. 1974 Jul;71(7):2915-8
4527668
Psychiatr Clin North Am. 1986 Mar;9(1):133-41
2421270
Int J Rad Appl Instrum B. 1991;18(8):871-81
1839303
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6412-6
2548214
Eur J Pharmacol. 1979 Apr 15;55(2):137-42
456412
Eur J Pharmacol. 1984 Jul 20;102(3-4):459-74
6149133
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):649-53
7904756